Literature DB >> 30687771

Eye Drops for Delivery of Bioactive Compounds and BrdU to Stimulate Proliferation and Label Mitotically Active Cells in the Adult Rodent Retina.

Cindy L Linn1, Sarah E Webster1, Mark K Webster1.   

Abstract

Eye drop treatments are typically used to apply drugs to the anterior structures of the eye. Recently, however, studies have demonstrated that eye drops can reach the retina in the back of the eye if pharmacological agents are carried in appropriate vehicles. Here, we introduce an eye drop procedure to deliver a drug (PNU-282987), in combination with BrdU, to stimulate cell cycle re-entry and label dividing cells in the retinas of adult rodents. This procedure avoids potential systemic complications of repeated intraperitoneal injections, as well as the retinal damage that is induced by repeated intravitreal injections. Although the delivery of PNU-282987 and BrdU is the focus of this article, many different proliferating compounds could be delivered to the retina using this procedure.

Entities:  

Keywords:  Adult rodents; BrdU; Eye drop delivery; Neurogenesis; PNU-282987; Proliferation; Retina

Year:  2018        PMID: 30687771      PMCID: PMC6347112          DOI: 10.21769/BioProtoc.3076

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  12 in total

1.  Evidence of BrdU-positive retinal neurons after application of an Alpha7 nicotinic acetylcholine receptor agonist.

Authors:  Mark K Webster; Cynthia A Cooley-Themm; Joseph D Barnett; Harrison B Bach; Jessica M Vainner; Sarah E Webster; Cindy L Linn
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

2.  Stimulation of neural regeneration in the mouse retina.

Authors:  Mike O Karl; Susan Hayes; Branden R Nelson; Kristine Tan; Brian Buckingham; Thomas A Reh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

3.  Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.

Authors:  Alice L Bodnar; Luz A Cortes-Burgos; Karen K Cook; Dac M Dinh; Vincent E Groppi; Mihaly Hajos; Nicole R Higdon; William E Hoffmann; Raymond S Hurst; Jason K Myers; Bruce N Rogers; Theron M Wall; Mark L Wolfe; Erik Wong
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

4.  A nicotinic acetylcholine receptor agonist prevents loss of retinal ganglion cells in a glaucoma model.

Authors:  Kazuhiro Iwamoto; Patrick Birkholz; Austin Schipper; David Mata; David M Linn; Cindy L Linn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-24       Impact factor: 4.799

5.  Time-Dependent Changes of Cell Proliferation After Laser Photocoagulation in Mouse Chorioretinal Tissue.

Authors:  Si Hyung Lee; Hoon Dong Kim; Yeo Jin Park; Young-Hoon Ohn; Tae Kwann Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

6.  Reduced cell proliferation and increased apoptosis in the hippocampal formation in a rat model of Hirschsprung's disease.

Authors:  Dan Xie; G David H Croaker; Jimei Li; Zan-Min Song
Journal:  Brain Res       Date:  2016-03-23       Impact factor: 3.252

7.  Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye.

Authors:  Mi Sun Sung; Zhengri Li; Lian Cui; Ji Suk Choi; Won Choi; Min Jung Park; Soo Hyun Park; Kyung Chul Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

8.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

9.  The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.

Authors:  M Hajós; R S Hurst; W E Hoffmann; M Krause; T M Wall; N R Higdon; V E Groppi
Journal:  J Pharmacol Exp Ther       Date:  2004-11-02       Impact factor: 4.030

10.  Retinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.

Authors:  David Mata; David M Linn; Cindy L Linn
Journal:  Neuropharmacology       Date:  2015-07-31       Impact factor: 5.250

View more
  3 in total

1.  BrdU Positive Cells Induced in a Genetic Mouse Model of Glaucoma.

Authors:  J R Paris; N C Sklar; C L Linn
Journal:  J Ophthalmol Vis Sci       Date:  2021-03-08

2.  Stimulation of Retinal Pigment Epithelium With an α7 nAChR Agonist Leads to Müller Glia Dependent Neurogenesis in the Adult Mammalian Retina.

Authors:  Mark K Webster; Betty J Barnett; Megan L Stanchfield; Joshua R Paris; Sarah E Webster; Cynthia A Cooley-Themm; Edward M Levine; Deborah C Otteson; Cindy L Linn
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-01       Impact factor: 4.799

3.  Stimulation of α7 nAChR leads to regeneration of damaged neurons in adult mammalian retinal disease models.

Authors:  Sarah E Webster; Nathan C Sklar; Jake B Spitsbergen; Megan L Stanchfield; Mark K Webster; David M Linn; Deborah C Otteson; Cindy L Linn
Journal:  Exp Eye Res       Date:  2021-08-01       Impact factor: 3.770

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.